perflutren has been researched along with Chemical and Drug Induced Liver Injury in 2 studies
*Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fritz, T; McKeon, M; Unger, E | 1 |
1 review(s) available for perflutren and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for perflutren and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Preclinical studies of MRX-115: safety evaluations of a myocardial perfusion agent.
Topics: Animals; Blood Pressure; Chemical and Drug Induced Liver Injury; Contrast Media; Dogs; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Fluorocarbons; Injections, Intravenous; Liver; Lung; Male; Mutagenicity Tests; Rats; Rats, Sprague-Dawley | 1996 |